These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4008516)

  • 1. Studies on high-dose chemotherapy of amygdalin in murine P388 lymphocytic leukaemia and P815 mast cell leukaemia.
    Chitnis MP; Adwankar MK; Amonkar AJ
    J Cancer Res Clin Oncol; 1985; 109(3):208-9. PubMed ID: 4008516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schedule dependence of activity of the amsacrine analogue CI-921 towards P388 leukaemia and Lewis lung carcinoma.
    Baguley BC; Grimwade CD; Kernohan AR
    Eur J Cancer Clin Oncol; 1985 Nov; 21(11):1337-41. PubMed ID: 3841068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thymidine on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II).
    Grossie VB; Valdivieso M; Drewinko B; Loo TL
    Cancer Chemother Pharmacol; 1984; 13(1):27-30. PubMed ID: 6539657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-histidinol improves the selectivity and efficacy of alkylating agents and daunomycin in mice with P388 leukaemia.
    Warrington RC; Fang WD
    Br J Cancer; 1989 Nov; 60(5):652-6. PubMed ID: 2803940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of amygdalin MF (NSC-15780) as a single agent and with beta-glucosidase (NSC-128056) on a spectrum of transplantable rodent tumors.
    Wodinsky I; Swiniarski JK
    Cancer Chemother Rep; 1975; 59(5):939-50. PubMed ID: 1203898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.
    Nogae I; Kikuchi J; Yamaguchi T; Nakagawa M; Shiraishi N; Kuwano M
    Br J Cancer; 1987 Sep; 56(3):267-72. PubMed ID: 3663474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
    Kamath NS; Chitnis MP
    Oncology; 1990; 47(2):166-9. PubMed ID: 2314829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors.
    Dye ES; North RJ
    J Leukoc Biol; 1984 Jul; 36(1):27-37. PubMed ID: 6234371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of anticancer agents with folic acid in the treatment of murine leukaemia P388.
    Parchure M; Ambaye RY; Gokhale SV
    Chemotherapy; 1984; 30(2):119-24. PubMed ID: 6697813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of dicyclohexylammonium sulfate, a potent inhibitor of spermidine synthase against P388 leukemia.
    Ito H; Hibasami H; Shimura K; Nagai J; Hidaka H
    Cancer Lett; 1982; 15(3):229-35. PubMed ID: 7116328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
    Laster WR; Schabel FM
    Cancer Chemother Rep; 1975; 59(5):951-65. PubMed ID: 1060511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy of early and advanced murine P388 leukaemia with bouvardin, cis-diamminedichloroplatinum and vincristine.
    Adwankar MK; Khandalekar DD; Chitnis MP
    Oncology; 1984; 41(5):370-3. PubMed ID: 6540853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compounds.
    Iigo M; Miwa M; Ishitsuka H; Nitta K
    Cancer Chemother Pharmacol; 1987; 19(1):61-4. PubMed ID: 3028664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity to anthracyclines in P388/dx leukaemia cells.
    Bossa R; Dasdia T; Galatulas I; Zunino F
    Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumour effect of alpha-amino N-substituted-pyrrolidin-2,5-dione-N-mustards on the growth of P388 lymphocytic leukaemia.
    Naik SD; Ambaye RY; Gokhale SV
    J Cancer Res Clin Oncol; 1987; 113(2):151-4. PubMed ID: 3455198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells by dipyrone.
    Chitnis MP; Kamath NS
    Oncology; 1987; 44(1):47-50. PubMed ID: 3561929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of P388 leukemia with benzaldehyde.
    Balázová E; Koza I
    Neoplasma; 1988; 35(6):725-8. PubMed ID: 3221939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI; Plunkett W
    Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lymph node metastasis of P388 leukemia by bestatin in mice.
    Tsuruo T; Naganuma K; Iida H; Yamori T; Tsukagoshi S; Sakurai Y
    J Antibiot (Tokyo); 1981 Sep; 34(9):1206-9. PubMed ID: 7328059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.